GSK plc announces the commencement of the final £0.18 billion tranche of its £2 billion share buyback programme on 11 May 2026 to complete the programme by end Q2 2026.
Key takeaways
Final tranche of up to £0.18 billion commences today, completing the £2 billion programme announced February 2025.
To date, repurchased 114,436,378 Ordinary Shares for £1.82 billion across first four tranches.
Agreement with Citigroup Global Markets Limited for non-discretionary purchases on London Stock Exchange and Cboe Europe.
Purchases expected to complete by 26 June 2026; shares held as Treasury shares.
Purpose: return excess capital to shareholders and reduce share capital, expected to enhance earnings per share.